Home › Products › Oncology › Apligraf 300mcg Injection

Apligraf 300mcg Injection

Salt Composition: FILGRASTIM

₹540.00₹1200.00

Inclusive of all taxes

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Apligraf 300mg Injection contains filgrastim, a granulocyte-colony stimulating factor (G-CSF) that helps the body produce more white blood cells (WBCs). It is used to reduce the risk and duration of neutropenia and febrile neutropenia in patients receiving chemotherapy for non-myeloid cancers. It is also indicated for acute myeloid leukemia, bone marrow transplantation, severe chronic neutropenia, and leukapheresis preparation. Additionally, it may improve survival following exposure to harmful radiation and help lower the risk of infections in patients with advanced HIV infection.

As a colony-stimulating factor, filgrastim increases WBC production, strengthening the body's ability to fight infections when blood cell counts are reduced by chemotherapy or other conditions. Patients should inform their physician about any history of liver disease, kidney problems, sickle cell anemia, or bone disease before treatment. Common side effects include fever, pain, rash, cough, shortness of breath, and nosebleeds.

Uses

The Apligraf 300mg Injection is used in the treatment of the following: To prevent infections after chemotherapy due to decreased white blood cells (neutropenia)

How it works

Apligraf 300mg Injection is a colony-stimulating factor that acts on blood-forming cells by binding to specific cell surface receptors, thereby inducing cell division, multiplication, and functional cell activation.

How to Use

Apligraf 300mg Injection is available as a prefilled syringe. A qualified healthcare professional will administer the injection in the fatty tissues just under your skin (subcutaneously) or it will be administered as an intravenous injection into your vein slowly. The dose, route of administration, and frequency will be decided by your doctor based on your disease condition and other factors. If your physician decides that you or your caregiver can administer the Apligraf 300mg Injection at home, then read the “Instructions for use” carefully from the package insert with the medicine. Your doctor or other healthcare professionals will train you on self-administration. Do not administer the medicine if you have not been trained and are not sure about the administration procedure.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common side effects of Apligraf 300mg Injection are: Pain in the bones, joints, and muscles Pain at the site of Injection Fever Itchiness and skin rash Nausea Headaches Dizziness and tiredness Nose bleeding Hair fall Serious side effects of Apligraf 300mg Injection are: Inflammation of Aorta Capillary leak syndrome (plasma leaks out of tiny blood vessels) Hypersensitivity reactions Changes in urine color Swelling in hands, feet, face, and abdomen Difficulty in breathing Sickle cell anemia

Expert Tips

Inform your physician if you are experiencing any symptoms of swelling in the face, feet, hands, and abdomen, difficulty in breathing, sudden drop in blood pressure, left abdominal pain, weakness, and skin rashes. If you use the prefilled syringe, allow the medicine to warm for 30 minutes at room temperature before injecting. Read the package insert carefully if you are self-administering the medicine. This medicine may cause lung, liver, or kidney problems. Your physician may advise you to take laboratory tests regularly to monitor the effectiveness of the therapy.

References

  1. 1. Neupogen Singleject 30 MU (0.6 mg/ml) - Patient Information Leaflet (PIL) - (emc) ww.medicines.org.uk. [Revised on 2022] [cited 2023 Mar 14]. Available from: https://www.medicines.org.uk/emc/product/608/pil 2. Neupogen 30 MU (0.3 mg/ml) solution for injection - Patient Information Leaflet (PIL) - (emc). www.medicines.org.uk. [Revised on 2022] [cited 2023 Mar 14]. Available from: https://www.medicines.org.uk/emc/product/3000/pil 3. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 876

Safety Advice

Pregnancy: unsafe Apligraf 300mg Injection is unsafe when administered during pregnancy because it may cause birth defects in your baby. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.

Lungs: Consult your doctor It is unknown whether Apligraf 300mg Injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe It is unsafe to breastfeed during treatment with this Apligraf 300mg Injection because it may cause harm to the baby. Please consult your doctor before breastfeeding.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS